Open AccessLetter to the Editor Regarding “A Prospective, Controlled Study of the Botanical Compound Mixture LCS101 for Chemotherapy‐Induced Hematological Complications in Breast Cancer” by Yaal‐Hahoshen et al. ( The Oncologist 2011;16:1197–1202)
Author(s) -
Mooiman Kim D.,
Goey Andrew K.L.,
Meijerman Irma,
Beijnen Jos H.,
Schellens Jan H.M.
Publication year - 2012
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2011-0413
Subject(s) - medicine , taxane , breast cancer , chemotherapy , oncology , anthracycline , prospective cohort study , cancer
A prospective, randomized, placebo‐controlled study by Yaal‐Hahoshen et al. published in a recent issue of The Oncologist that concluded that the botanical mixture LCS101 prevented hematological complications in breast cancer patients undergoing anthracycline‐ and taxane‐based chemotherapy is critically reviewed.